Meghan Chenoweth, University of Toronto

Research

Anxiety Genetics Genome-Wide Association Study Mendelian Randomization Migraine Sex And Gender Differences Underfunded Diseases Cigarette Smoking

Latest papers

Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020

All 1 publications

Latest funding

The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
CIHR · 2026 · Co-investigator
$100,000
A Phase II Multi-Site, Double-Blind, Randomized, Sham-Controlled, Clinical Trial of Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
CIHR · 2025 · Co-investigator
$1,468,800
Uncovering the biological liability to migraine and anxiety in women
CIHR · 2023 · Nominated PI
$149,500

All 7 grants and awards

1 publications.

01

Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes.

Chen J, Loukola A, Gillespie NA, Peterson R, Jia P, Riley B, Maes H, Dick DM, Kendler KS, Damaj MI, Miles MF, Zhao Z, Li MD, Vink JM, Minica CC, Willemsen G, Boomsma DI, Qaiser B, Madden PAF, Korhonen T, Jousilahti P, Hällfors J, Gelernter J, Kranzler HR, Sherva R, Farrer L, Maher B, Vanyukov M, Taylor M, Ware JJ, Munafò MR, Lutz SM, Hokanson JE, Gu F, Landi MT, Caporaso NE, Hancock DB, Gaddis NC, Baker TB, Bierut LJ, Johnson EO, Chenoweth M, Lerman C, Tyndale R, Kaprio J, Chen X

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2020

DOI: 10.1093/ntr/ntz099 PMID: 31294817

The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.

Co-investigatorCIHR2026Project Grant

Principal investigators: Selby, Peter L; Agarwal, Sri Mahavir; Melamed, Osnat; Mir, Hassan; Patton, Ian T; Tang, Victor M; Veldhuizen, Scott R; Zawertailo, Laurie A

Keywords: Addiction; Cardiometabolic Risk; Gastric Inhibitory Peptide; Glucagon-Like Peptide-1 Receptor Agonist; Nicotine Dependence; Obesity; Overweight; Smoking Cessation; Tobacco Use Disorder; Trizepatide

$100,000

A Phase II Multi-Site, Double-Blind, Randomized, Sham-Controlled, Clinical Trial of Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder

Co-investigatorCIHR2025Project Grant - Priority Announcement: Integrated Cannabis Research Strategy

Principal investigators: Tang, Victor M; Blumberger, Daniel M; MacKillop, James

Keywords: Addiction; Cannabis; Cannabis Use Disorder; Neuromodulation; Transcranial Magnetic Stimulation

$1,468,800

Uncovering the biological liability to migraine and anxiety in women

Nominated PICIHR2023Catalyst Grant: NWHRI: Innovation Fund - Biomedical Discovery Grants

Principal investigators: Chenoweth, Meghan J

Keywords: Anxiety; Genetics; Genome-Wide Association Study; Mendelian Randomization; Migraine; Sex And Gender Differences; Underfunded Diseases

$149,500

Genetic impact on youth vaping: extending known genetic risk factors in smoking and tobacco-related illnesses to vaping

Nominated PICIHR2020Catalyst Grant: Health Effects of Vaping

Principal investigators: Chenoweth, Meghan J; Tyndale, Rachel F

Keywords: Cigarette Smoking; Cohort Study; Gender Differences; Genetic Risk Factors; Health Effects; Pharmacogenetics; Sex Differences; Vaping; Young Adults; Youth

$99,942

Precision medicine in smoking cessation: nicotine metabolism genetics in nine clinical trials

Co-investigatorCIHR2018Project Grant

Principal investigators: Knight, Jo

Keywords: Biomarkers; Nicotine Metabolism; Precision Medicine; Smoking Cessation; Tobacco

$929,475

Do men and women differ in how pharmacogenetics optimizes smoking cessation therapy?

Co-investigatorCIHR2017Catalyst Grant: Personalized Health Catalyst Grants

Principal investigators: Tyndale, Rachel F

Keywords: Gender Differences; Medication Adherence; Personalized Medicine; Pharmacogenetics; Pharmacokinetic Variation; Sex Differences; Smoking Cessation

$199,619

Variation in nicotine metabolism in nine clinical trials: a genomics approach to personalizing smoking cessation

Co-investigatorCIHR2016Project Grant

Principal investigators: Tyndale, Rachel F

Keywords: Biomarkers; Nicotine Metabolism; Precision Medicine; Smoking Cessation; Tobacco

$753,524

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Rachel Tyndale

Department of Pharmacology and Toxicology

1 shared papers, latest 2020

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Anxiety Dear Professor Chenoweth, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes." (2020), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Uncovering the biological liability to migraine and anxiety in women" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]